Blair William & Co. IL lifted its stake in CME Group Inc. (NASDAQ:CME) by 15.8% during the 4th quarter, Holdings Channel reports. The institutional investor owned 171,609 shares of the financial services provider’s stock after buying an additional 23,445 shares during the period. Blair William & Co. IL’s holdings in CME Group were worth $31,241,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CME. Rockbridge Investment Management LCC increased its holdings in CME Group by 1,663.6% during the 3rd quarter. Rockbridge Investment Management LCC now owns 194 shares of the financial services provider’s stock valued at $32,000 after purchasing an additional 183 shares during the period. Paces Ferry Wealth Advisors LLC purchased a new position in CME Group during the 3rd quarter valued at about $33,000. HHM Wealth Advisors LLC increased its holdings in CME Group by 624.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 181 shares of the financial services provider’s stock valued at $33,000 after purchasing an additional 156 shares during the period. CVA Family Office LLC purchased a new position in CME Group during the 3rd quarter valued at about $38,000. Finally, Eudaimonia Partners LLC increased its holdings in CME Group by 67.9% during the 3rd quarter. Eudaimonia Partners LLC now owns 225 shares of the financial services provider’s stock valued at $38,000 after purchasing an additional 91 shares during the period. Hedge funds and other institutional investors own 83.88% of the company’s stock.
A number of brokerages recently issued reports on CME. JPMorgan Chase & Co. upgraded CME Group from an “underweight” rating to a “neutral” rating and boosted their price target for the company from $138.00 to $203.00 in a report on Thursday, January 7th. Rosenblatt Securities reduced their target price on CME Group from $140.00 to $135.00 and set a “sell” rating on the stock in a report on Wednesday, January 6th. Citigroup reduced their target price on CME Group from $210.00 to $207.00 and set a “buy” rating on the stock in a report on Thursday, February 11th. Oppenheimer downgraded CME Group from an “outperform” rating to a “market perform” rating in a report on Friday, January 15th. They noted that the move was a valuation call. Finally, Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and set a $196.00 target price on the stock. in a report on Friday, January 8th. They noted that the move was a valuation call. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have assigned a buy rating to the stock. CME Group has a consensus rating of “Hold” and an average price target of $187.59.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Tuesday, February 9th. The financial services provider reported $1.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.03. The business had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.10 billion. CME Group had a return on equity of 9.22% and a net margin of 43.68%. The firm’s quarterly revenue was down 3.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.52 EPS. On average, research analysts predict that CME Group Inc. will post 6.69 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Thursday, March 25th. Shareholders of record on Wednesday, March 10th will be paid a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, March 9th. This is a positive change from CME Group’s previous quarterly dividend of $0.85. This represents a $3.60 dividend on an annualized basis and a yield of 1.84%. CME Group’s payout ratio is currently 50.00%.
In other CME Group news, insider Julie Winkler sold 4,059 shares of the business’s stock in a transaction on Monday, December 14th. The shares were sold at an average price of $181.02, for a total transaction of $734,760.18. Following the completion of the sale, the insider now directly owns 24,921 shares in the company, valued at approximately $4,511,199.42. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Martin J. Gepsman sold 800 shares of the business’s stock in a transaction on Tuesday, December 1st. The shares were sold at an average price of $178.60, for a total transaction of $142,880.00. Following the sale, the director now owns 29,817 shares of the company’s stock, valued at $5,325,316.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,559 shares of company stock valued at $2,450,936. Company insiders own 1.20% of the company’s stock.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products through its electronic trading platforms, open outcry, and privately negotiated transactions.
Recommended Story: What is the accumulation/distribution indicator?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.